Precigen, Inc.

Precigen is a commercial-stage biopharmaceutical company advancing precision medicines through gene and cell therapies. Its mission is to develop and commercialize targeted treatments for difficult-to-treat diseases, addressing significant unmet medical needs in immuno-oncology, autoimmune disorders, and infectious diseases. The company’s AdenoVerse immunotherapy and UltraCAR-T platforms underpin a pipeline of therapies and support its work from clinical development through commercialization.